Regression of Infantile Glioblastoma After First-Line Treatment With Larotrectinib.
作者信息
Alharbi Musa, Mobark Nahla Ali, Balbaid Ali Abdullah O, Alanazi Fatmah A, Aljabarat Wael Abdel Rahman, Bakhsh Eman A, Ramkissoon Shakti H, Abedalthagafi Malak
机构信息
Department of Paediatric Oncology, Comprehensive Cancer Centre, King Fahad Medical, Riyadh, Saudi Arabia.
Radiation Oncology Department, Comprehensive Cancer Centre, King Fahad Medical City, Riyadh, Saudi Arabia.
出版信息
JCO Precis Oncol. 2020 Jun 30;4. doi: 10.1200/PO.20.00017. eCollection 2020.
Abstract
摘要
相似文献
1
Regression of Infantile Glioblastoma After First-Line Treatment With Larotrectinib.
JCO Precis Oncol. 2020 Jun 30;4. doi: 10.1200/PO.20.00017. eCollection 2020.
2
Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusion.
Ann Oncol. 2019 Nov;30 Suppl 8:viii31-viii35. doi: 10.1093/annonc/mdz382. Epub 2019 Dec 24.
3
Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusion.
Ann Oncol. 2019 Nov 1;30(Suppl_8):viii31-viii35. doi: 10.1093/annonc/mdz382.
4
Congenital mesoblastic nephroma t(12;15) is associated with ETV6-NTRK3 gene fusion: cytogenetic and molecular relationship to congenital (infantile) fibrosarcoma.
Am J Pathol. 1998 Nov;153(5):1451-8. doi: 10.1016/S0002-9440(10)65732-X.
5
Congenital-infantile fibrosarcoma. A clinicopathologic study of 10 cases and molecular detection of the ETV6-NTRK3 fusion transcripts using paraffin-embedded tissues.
Am J Clin Pathol. 2001 Mar;115(3):348-55. doi: 10.1309/3H24-E7T7-V37G-AKKQ.
6
Molecular detection of the ETV6-NTRK3 gene fusion differentiates congenital fibrosarcoma from other childhood spindle cell tumors.
Am J Surg Pathol. 2000 Jul;24(7):937-46. doi: 10.1097/00000478-200007000-00005.
7
Transcriptome sequencing identifies ETV6-NTRK3 as a gene fusion involved in GIST.
J Pathol. 2016 Mar;238(4):543-9. doi: 10.1002/path.4677. Epub 2016 Jan 25.
8
A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma.
Nat Genet. 1998 Feb;18(2):184-7. doi: 10.1038/ng0298-184.
9
Cellular transformation and activation of the phosphoinositide-3-kinase-Akt cascade by the ETV6-NTRK3 chimeric tyrosine kinase requires c-Src.
Cancer Res. 2007 Apr 1;67(7):3192-200. doi: 10.1158/0008-5472.CAN-06-3526.
10
Mediators of receptor tyrosine kinase activation in infantile fibrosarcoma: a Children's Oncology Group study.
J Pathol. 2012 Sep;228(1):119-30. doi: 10.1002/path.4010. Epub 2012 Jul 2.
引用本文的文献
1
TRK Inhibitors in Adult and Pediatric High-Grade Gliomas: A Systematic Review and Individual Participant Data Meta-Analysis.
Cancers (Basel). 2025 Jun 23;17(13):2089. doi: 10.3390/cancers17132089.
2
Rare variant of large pediatric glioneuronal tumor with novel MYO5A::NTRK3 fusion: illustrative case.
J Neurosurg Case Lessons. 2024 Mar 4;7(10). doi: 10.3171/CASE23638.
3
Screening of predicted synergistic multi-target therapies in glioblastoma identifies new treatment strategies.
Neurooncol Adv. 2023 Jun 13;5(1):vdad073. doi: 10.1093/noajnl/vdad073. eCollection 2023 Jan-Dec.
4
A comprehensive analysis of infantile central nervous system tumors to improve distinctive criteria for infant-type hemispheric glioma versus desmoplastic infantile ganglioglioma/astrocytoma.
Brain Pathol. 2023 Sep;33(5):e13182. doi: 10.1111/bpa.13182. Epub 2023 Jun 22.
5
Role of Molecular Targeted Therapeutic Drugs in Treatment of Glioblastoma: A Review Article.
Glob Med Genet. 2023 Apr 17;10(2):42-47. doi: 10.1055/s-0043-57028. eCollection 2023 Jun.
6
Signaling pathways in brain tumors and therapeutic interventions.
Signal Transduct Target Ther. 2023 Jan 4;8(1):8. doi: 10.1038/s41392-022-01260-z.
7
NTRK Gene Fusions in Solid Tumors and TRK Inhibitors: A Systematic Review of Case Reports and Case Series.
J Pers Med. 2022 Nov 2;12(11):1819. doi: 10.3390/jpm12111819.
8
Entrectinib demonstrates prolonged efficacy in an adult case of radiation-refractory fusion glioblastoma.
Neurooncol Adv. 2022 Apr 13;4(1):vdac046. doi: 10.1093/noajnl/vdac046. eCollection 2022 Jan-Dec.
9
Glioma targeted therapy: insight into future of molecular approaches.
Mol Cancer. 2022 Feb 8;21(1):39. doi: 10.1186/s12943-022-01513-z.
10
Childhood Malignant Brain Tumors: Balancing the Bench and Bedside.
Cancers (Basel). 2021 Dec 3;13(23):6099. doi: 10.3390/cancers13236099.
本文引用的文献
1
Clinical management and genomic profiling of pediatric low-grade gliomas in Saudi Arabia.
PLoS One. 2020 Jan 29;15(1):e0228356. doi: 10.1371/journal.pone.0228356. eCollection 2020.
2
Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusion.
Ann Oncol. 2019 Nov 1;30(Suppl_8):viii31-viii35. doi: 10.1093/annonc/mdz382.
3
Significance of liquid biopsy in glioblastoma - A review.
J Biotechnol. 2019 Jun 10;298:82-87. doi: 10.1016/j.jbiotec.2019.04.011. Epub 2019 Apr 12.
4
Larotrectinib in NTRK-Rearranged Solid Tumors.
Biochemistry. 2019 Mar 26;58(12):1555-1557. doi: 10.1021/acs.biochem.9b00126. Epub 2019 Mar 13.
5
Immunogenetics of glioblastoma: the future of personalized patient management.
NPJ Precis Oncol. 2018 Dec 4;2:27. doi: 10.1038/s41698-018-0070-1. eCollection 2018.
6
Comprehensive genomic profiling identifies novel NTRK fusions in neuroendocrine tumors.
Oncotarget. 2018 Nov 9;9(88):35809-35812. doi: 10.18632/oncotarget.26260.
7
NTRK fusion-positive cancers and TRK inhibitor therapy.
Nat Rev Clin Oncol. 2018 Dec;15(12):731-747. doi: 10.1038/s41571-018-0113-0.
8
Brief Report: Potent clinical and radiological response to larotrectinib in TRK fusion-driven high-grade glioma.
Br J Cancer. 2018 Sep;119(6):693-696. doi: 10.1038/s41416-018-0251-2. Epub 2018 Sep 17.
9
The use of neoadjuvant larotrectinib in the management of children with locally advanced TRK fusion sarcomas.
Cancer. 2018 Nov 1;124(21):4241-4247. doi: 10.1002/cncr.31701. Epub 2018 Sep 11.
10
Molecular characterization of cancers with NTRK gene fusions.
Mod Pathol. 2019 Jan;32(1):147-153. doi: 10.1038/s41379-018-0118-3. Epub 2018 Aug 31.
Zotero 插件